Combinostics
Combinostics offers a complete AI solution for the entire patient care pathway of major neurological disorders. Their cNeuro® platform integrates cNeuro® cMRI™ for automated brain MRI quantification and cNeuro cDSI™ for AI-supported diagnosis and progression prediction. By combining imaging data with clinical, demographic, and test results, the platform provides clinicians with a holistic view to make confident, evidence-based decisions. The company aims to support early detection, diagnosis, and management of neurological conditions like Alzheimer's disease and dementia, leveraging patented disease state fingerprint technology.
Combinostics
Combinostics offers a complete AI solution for the entire patient care pathway of major neurological disorders. Their cNeuro® platform integrates cNeuro® cMRI™ for automated brain MRI quantification and cNeuro cDSI™ for AI-supported diagnosis and progression prediction. By combining imaging data with clinical, demographic, and test results, the platform provides clinicians with a holistic view to make confident, evidence-based decisions. The company aims to support early detection, diagnosis, and management of neurological conditions like Alzheimer's disease and dementia, leveraging patented disease state fingerprint technology.